ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO924

TAZ Plays an Important Role in Maintenance of Podocyte Viability

Session Information

Category: Development, Stem Cells, and Regenerative Medicine

  • 501 Development, Stem Cells, and Regenerative Medicine: Basic

Authors

  • Chen, Jianchun, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Harris, Raymond C., Vanderbilt University Medical Center, Nashville, Tennessee, United States
Background

TAZ (also known as WWTR1), a paralogue of YAP, is an important nuclear effector of the Hippo signaling pathway. TAZ shares 45% amino acid identity with YAP and they share some redundant roles in some organ development, but they also differ in some functions. TAZ is highly expressed in kidney, especially in renal proximal tubule cells. TAZ global knockout causes early mortality in a subset of homozygous mice, while bilateral kidney cysts and a pulmonary emphysema-like phenotype presented in the surviving adult mice. YAP is highly expressed in the nucleus of podocytes, and podocyte-specific deletion of YAP causes FSGS and progressive renal failure. The goal of these studies was to determine whether TAZ also plays a physiologic role in podocytes.

Methods

Mice with podocyte-TAZ deletion (TAZpodKO) were generated by crossing TAZflox/flox mice with podocin-Cre recombinase transgenic mice. Urinary albumin excretion and kidney histology and podocyte number per glomerulus were evaluated in TAZpodKO and WT mice. Immunoblotting analysis of isolated glomerulus lysates of TAZpodKO or TAZpodWT mice were performed. In cultured mouse podocytes, cell morphology and cell lysates were evaluated after silencing TAZ with specific siRNAs.

Results

41.7% of TAZpodKO mice develop mild proteinuria at age of 3-4 weeks (n=36), with a urine albumin/creatinine ratio of 89.57 ± 12.67 vs 27.86 ± 1.55 (µg/mg, n=7). At 9 weeks of age, compared to TAZpodWT mice, the glomeruli of TAZpodKO mouse kidney had focal sclerosis and significant podocyte loss (WT1+ cells: 13.23 ± 0.699 vs. 17.85 ± 0.608 (n=13). There was increased YAP expression and nuclear localization in the TAZpodKO mice compared with TAZpodWT mice. Glomeruli of TAZpodKO mice had increased cleaved-caspase 3 and decreased Bcl2 expression. In cultured podocytes, silencing TAZ by siRNA altered cell morphology and F-actin distribution, up-regulated of cleaved-caspase 3 and inhibited Bcl2 expression.

Conclusion

This study demonstrates that TAZ expression plays an important role in maintenance of podocytes, which cannot be compensated by its paralogue YAP.

Funding

  • NIDDK Support